Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Thermodesulfobacterium geofontis OPF15

ABSTRACT: Thermodesulfobacterium geofontis OPF15 Genome sequencing

PROVIDER: PRJNA67515 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR190876_1.fastq.gz	Fastqsanger.gz
	SRR190876_2.fastq.gz	Fastqsanger.gz
	SRR3927493_1.fastq.gz	Fastqsanger.gz
	SRR3927493_2.fastq.gz	Fastqsanger.gz
	GCA_000215975.1_sequence_report.txt	Txt

Items per page:

1 - 5 of 5

Similar Datasets

Thermodesulfobacterium sp. TA1

Project description:Thermodesulfobacterium sp. TA1 Genome sequencing

| PRJNA565031 | ENA

Thermodesulfobacterium thermophilum

Project description:Thermodesulfobacterium thermophilum overview

| PRJNA189085 | ENA

Thermodesulfobacterium hveragerdense

Project description:Thermodesulfobacterium hveragerdense overview

| PRJNA185951 | ENA

Thermodesulfobacterium commune DSM 2178

Project description:Thermodesulfobacterium commune DSM 2178 Genome sequencing and assembly

| PRJNA239504 | ENA

Thermodesulfobacterium hveragerdense DSM 12571

Project description:Thermodesulfobacterium hveragerdense DSM 12571

| PRJNA185672 | ENA

Thermodesulfobacterium thermophilum DSM 1276

Project description:Thermodesulfobacterium thermophilum DSM 1276

| PRJNA188822 | ENA

Thermodesulfobacterium hydrogeniphilum strain:DSM 14290

Project description:Thermodesulfobacterium hydrogeniphilum strain:DSM 14290 Genome sequencing and assembly

| PRJNA239492 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Thermodesulfobacterium

Project description:Group of uncharacterized isolates

| PRJNA164337 | ENA

Thermodesulfobacterium commune

Project description:Hyperthermophilic sulfate reducing bacterium

| PRJNA35349 | ENA